Literature DB >> 15627206

Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma.

Yasuaki Arakawa1, Osamu Tachibana, Mitsuhiro Hasegawa, Tadao Miyamori, Junkoh Yamashita, Yutaka Hayashi.   

Abstract

The decoy receptor 3 (DcR3) gene is amplified at high frequency in human lung, colon, and liver cancers. DcR3 has been demonstrated to produce a secreted member of the tumor necrosis factor receptor superfamily that negatively regulates Fas-mediated apoptosis. In this study we examined DcR3 gene amplification, DcR3 mRNA expression, and DcR3 protein expression in 46 human astrocytic brain tumors by quantitative genomic PCR, quantitative reverse transcription-PCR, and immunohistochemistry, respectively. The DcR3 gene amplification was detected in none of 6 (0%) low-grade astrocytomas, 1 of 16 (6%) anaplastic astrocytomas, and 6 of 24 ( 25%) glioblastomas. Six of 7 (86%) cases with gene amplification exhibited both mRNA overexpression and/or protein overexpression, suggesting that DcR3 mRNA and protein were expressed more abundantly in the cases with gene amplification. We thus concluded that high DcR3 mRNA expression and protein expression may be positively related to the gene amplification in astrocytic brain tumors, especially glioblastomas. Further, we speculated that the DcR3 gene amplification with overexpression may be responsible for malignant features in glioblastomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15627206     DOI: 10.1007/s00401-004-0956-6

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  15 in total

1.  Prognostic and clinicopathological differences of DcR3 in gastrointestinal cancer: evidence from meta-analysis.

Authors:  Jing Tong; Ran Ao; Ying Wang; Bing Chang; Bing-Yuan Wang
Journal:  Int J Clin Exp Med       Date:  2014-09-15

2.  Modulation of CCAAT/enhancer binding protein homologous protein (CHOP)-dependent DR5 expression by nelfinavir sensitizes glioblastoma multiforme cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

Authors:  Xiaobing Tian; Jiangbin Ye; Michelle Alonso-Basanta; Stephen M Hahn; Constantinos Koumenis; Jay F Dorsey
Journal:  J Biol Chem       Date:  2011-06-22       Impact factor: 5.157

3.  Anti-cancer effects of the HuR inhibitor, MS-444, in malignant glioma cells.

Authors:  Jiping Wang; Anita B Hjelmeland; L Burt Nabors; Peter H King
Journal:  Cancer Biol Ther       Date:  2019-04-16       Impact factor: 4.742

4.  Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer.

Authors:  Chen Zhang; Haoran Li; Yujie Huang; Yuchen Tang; Jie Wang; Yinxiang Cheng; Yijun Wei; Dongming Zhu; Zhifei Cao; Jian Zhou
Journal:  J Gastrointest Oncol       Date:  2021-08

5.  Decoy receptor 3 is a prognostic factor in renal cell cancer.

Authors:  Stephan Macher-Goeppinger; Sebastian Aulmann; Nina Wagener; Benjamin Funke; Katrin E Tagscherer; Axel Haferkamp; Markus Hohenfellner; Sunghee Kim; Frank Autschbach; Peter Schirmacher; Wilfried Roth
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

6.  Genome-wide association study identifies five susceptibility loci for glioma.

Authors:  Sanjay Shete; Fay J Hosking; Lindsay B Robertson; Sara E Dobbins; Marc Sanson; Beatrice Malmer; Matthias Simon; Yannick Marie; Blandine Boisselier; Jean-Yves Delattre; Khe Hoang-Xuan; Soufiane El Hallani; Ahmed Idbaih; Diana Zelenika; Ulrika Andersson; Roger Henriksson; A Tommy Bergenheim; Maria Feychting; Stefan Lönn; Anders Ahlbom; Johannes Schramm; Michael Linnebank; Kari Hemminki; Rajiv Kumar; Sarah J Hepworth; Amy Price; Georgina Armstrong; Yanhong Liu; Xiangjun Gu; Robert Yu; Ching Lau; Minouk Schoemaker; Kenneth Muir; Anthony Swerdlow; Mark Lathrop; Melissa Bondy; Richard S Houlston
Journal:  Nat Genet       Date:  2009-07-05       Impact factor: 38.330

7.  Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas.

Authors:  Ahmed Idbaih; Emmanuelle Crinière; Yannick Marie; Audrey Rousseau; Karima Mokhtari; Michèle Kujas; Younas El Houfi; Catherine Carpentier; Sophie Paris; Blandine Boisselier; Florence Laigle-Donadey; Joëlle Thillet; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Journal:  Neuro Oncol       Date:  2008-06-10       Impact factor: 12.300

8.  Effect of DcR3-specific siRNA on cell growth suppression and apoptosis induction in glioma cells via affecting ERK and AKT.

Authors:  Yu Zhang; Suning Huang; Yuhua Leng; Xin Chen; Tiantian Liu; Hanlin Wang; Fanglin Wei; Dianzhong Luo; Gang Chen; Zhuxin Wei
Journal:  Onco Targets Ther       Date:  2016-08-29       Impact factor: 4.147

9.  Overexpression of DcR3 and its significance on tumor cell differentiation and proliferation in glioma.

Authors:  Suning Huang; Gang Chen; Yiwu Dang; Long-Hua Chen
Journal:  ScientificWorldJournal       Date:  2014-03-05

10.  Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases.

Authors:  Yu Zhang; Jie Luo; Rongquan He; Wenting Huang; Zuyun Li; Ping Li; Yiwu Dang; Gang Chen; Shikang Li
Journal:  Onco Targets Ther       Date:  2016-08-10       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.